Technical analysis of Vera Therapeutics, Inc. (VERA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A nephropathy.
Price Performance
| 1 month | +1.41% |
| 3 months | -5.53% |
| Year-to-date | -40.26% |
| 1 year | +24.23% |
| 3 years | +187.55% |
| 5 years | +53.16% |
52-Week Range
| 52-week High | $56.05 |
| 52-week Low | $23.05 |
| Avg Volume (90d) | 2.2M |
Technical Indicators
| SMA 50 | $31.96 |
| SMA 200 | $36.88 |
| Beta | 1.17 |
| 30-day Volatility (annualised) | 60.5% |
| Price vs SMA 50 | -5.3% |
| Price vs SMA 200 | -18.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $50.64 | |
| 2026-01 | $43.26 | -14.6% |
| 2026-02 | $40.79 | -5.7% |
| 2026-03 | $40.23 | -1.4% |
| 2026-04 | $35.61 | -11.5% |
| 2026-05 | $35.52 | -0.3% |
| 2026-06 | $42.91 | +20.8% |
| 2026-07 | $32.10 | -25.2% |
| 2026-08 | $34.08 | +6.2% |
| 2026-09 | $32.29 | -5.3% |
| 2026-10 | $30.98 | -4.1% |
| 2026-11 | $30.25 | -2.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-05 | $-1.62 | $3M |
| 2026-08-10 | $-1.58 | $1M |
| 2026-05-07 | $-1.33 | |
| 2026-02-26 | $-1.34 | |
| 2025-11-05 | $-1.20 | |
| 2025-08-05 | $-0.82 | |
| 2025-05-06 | $-0.75 | |
Price
| Price | $30.71 (closing price, November 3, 2026) |
| Market Cap | $2.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 5.41 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.18 |
| Current Ratio | 10.92 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 13.22 |